Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $30.5 Million - $37.8 Million
-230,900 Reduced 91.52%
21,400 $3.47 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $21.6 Million - $27.4 Million
201,400 Added 395.68%
252,300 $34.2 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $3.59 Million - $4 Million
-34,100 Reduced 40.12%
50,900 $5.73 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $6.84 Million - $9.24 Million
85,000 New
85,000 $9.11 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.